Maccecchini Maria-Luisa
SEC insider (Form 3/4/5 filer). CIK 0001315018. Director at Lantern Pharma Inc. (LTRN) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 9, 2026. Located in DALLAS, TX.
Companies Maccecchini Maria-Luisa has filed insider reports for
- Lantern Pharma Inc. (LTRN): Director
- Annovis Bio, Inc. (ANVS): Director, Officer, President & CEO
Maccecchini Maria-Luisa
CIK: 0001315018
Transaction Breakdown
Open Market Buys (P)1 (25.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 9, 2026LTRN
Lantern Pharma Inc.
AwardDirectStock Option (Right to Buy)
25K shares- - Jan 9, 2026LTRN
Lantern Pharma Inc.
AwardDirectStock Option (Right to Buy)
21.2K shares- - Oct 28, 2025ANVS
Annovis Bio, Inc.
PurchaseDirect97.6K shares at avg. $2.05$200K - Jun 4, 2025ANVS
Annovis Bio, Inc.
AwardDirect46K shares at avg. $3.37$155K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 9, 2026 |  LTRN Lantern Pharma Inc. | Award Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| Jan 9, 2026 | LTRN Lantern Pharma Inc. | Award Stock Option (Right to Buy) | 21,152 | - | - | Direct |
| Oct 28, 2025 |  ANVS Annovis Bio, Inc. | Purchase | 97,561 | $2.05 | $200,000 | Direct |
| Jun 4, 2025 | ANVS Annovis Bio, Inc. | Award | 46,000 | $3.37 | $155,020 | Direct |
1-4 of 4 transactions